(Q37133994)

18 August 2017

1 reference

title

Plasticity of the cancer cell: implications for epigenetic control of melanoma and other malignancies (English)

1 reference

18 August 2017

George Lipkin

1

1 reference

PubMed ID

18401428

18 August 2017

language of work or name

English

0 references

publication date

10 April 2008

1 reference

Journal of Investigative Dermatology

18 August 2017

1 reference

18 August 2017

128

1 reference

18 August 2017

2152-2155

1 reference

18 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2008.69

18 August 2017

0 references

cites work

Fibroblasts can modulate the phenotype of malignant epithelial cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Wounding and its role in RSV-mediated tumor formation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Cancer chemotherapy targeted at reactivating the expression of epigenetically inactivated genes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

A tumorigenic subpopulation with stem cell properties in melanomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

The history of cancer epigenetics

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Morphogenesis of human colon cancer cells with fetal rat mesenchymes in organ culture

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Molecular plasticity of human melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Reduced expression of dystroglycan in breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Cancer epigenetics comes of age

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Reactivating the expression of methylation silenced genes in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Histone deacetylase inhibitors: from target to clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Tumor reversion: Correction of malignant behavior by microenvironmental cues

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

CEACAM1-4S, a cell-cell adhesion molecule, mediates apoptosis and reverts mammary carcinoma cells to a normal morphogenic phenotype in a 3D culture

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

A Diffusible Factor Restoring Contact Inhibition of Growth to Malignant Melanocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Contact inhibition of growth is restored to malignant melanocytes of man and mouse by a hamster protein

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Contact inhibitory factor also restores anchorage and serum dependence to hamster melanoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Normal genetically mosaic mice produced from malignant teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Know thy neighbor: stromal cells can contribute oncogenic signals

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Genetic alterations during colorectal-tumor development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2008.69

7 January 2021

Identifiers

DOI

10.1038/JID.2008.69

1 reference

18 August 2017

1 reference

PubMed ID

18401428